Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance
- 1 July 1987
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 31 (7) , 1054-1060
- https://doi.org/10.1128/aac.31.7.1054
Abstract
An in vitro pharmacokinetic model was used to study the comparative antibacterial activities of multiple-dose regimens of enoxacin and netilmicin. Strains of Pseudomonas aeruginosa, Klebsiella pneumoniae, Escherichia coli, and Staphylococcus aureus were exposed to changing drug concentrations, mimicking human two-compartment pharmacokinetics. Oral administration was simulated for the quinolone, and intravenous administration was simulated for the aminoglycoside. Similar ratios of peak concentration to MIC resulted in similar changes in bacterial concentrations over time with both compounds. Following the initial dose, a rapid bactericidal effect occurred, with a > 99% reduction of the bacterial counts within 4 h at peak concentrations more than three times the MIC. However, bacterial regrowth occurred within 24 h unless the peak concentration/MIC ratio exceeded 8:1 (P < 0.01). For the regrowing bacteria, MICs were four- to eightfold higher, and little or no bactericidal effect occurred following the second and subsequent doses. These data demonstrate the equally potent bactericidal activity of orally administered enoxacin and intravenously administered netilmicin. Selection of resistant subpopulations was similar with each drug. The peak concentration/MIC ratio may be an important parameter in the clinical use of quinolone and aminoglycoside antibiotics.This publication has 17 references indexed in Scilit:
- Clinical Response to Aminoglycoside Therapy: Importance of the Ratio of Peak Concentration to Minimal Inhibitory ConcentrationThe Journal of Infectious Diseases, 1987
- Influence of medium and method on the in vitro susceptibility of Pseudomonas aeruginosa and other bacteria to ciprofloxacin and enoxacinAntimicrobial Agents and Chemotherapy, 1986
- The fluoroquinolones: pharmacology, clinical uses, and toxicities in humansAntimicrobial Agents and Chemotherapy, 1985
- The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitroAntimicrobial Agents and Chemotherapy, 1985
- Impact of netilmicin regimens on the activities of ceftazidime-netilmicin combinations against Pseudomonas aeruginosa in an in vitro pharmacokinetic modelAntimicrobial Agents and Chemotherapy, 1985
- Efficacy of intermittent versus continuous administration of netilmicin in a two-compartment in vitro modelAntimicrobial Agents and Chemotherapy, 1985
- Selection of multiple antibiotic resistance by quinolones, beta-lactams, and aminoglycosides with special reference to cross-resistance between unrelated drug classesAntimicrobial Agents and Chemotherapy, 1984
- Pharmacokinetics and tissue penetration of enoxacinAntimicrobial Agents and Chemotherapy, 1984
- Selection of Aminoglycoside-Resistant Variants of Pseudomonas aeruginosa in an in Vivo ModelThe Journal of Infectious Diseases, 1982
- Postantibiotic Leukocyte Enhancement: Increased Susceptibility of Bacteria Pretreated with Antibiotics to Activity of LeukocytesClinical Infectious Diseases, 1981